Advance on nitric oxide combined photothermal therapy for tumor treatment
10.16438/j.0513-4870.2022-0875
- VernacularTitle:基于一氧化氮联合光热疗法用于肿瘤治疗的研究进展
- Author:
Yue HUANG
;
Ke-xin LI
;
Dan QING
;
Yue YANG
;
Xiao-tian BAI
;
Zhi-hong BAO
- Publication Type:Research Article
- Keywords:
photothermal therapy;
nitric oxide;
combination therapy;
antitumor;
mechanism
- From:
Acta Pharmaceutica Sinica
2023;58(2):274-284
- CountryChina
- Language:Chinese
-
Abstract:
Photothermal therapy (PTT) has attracted significant attention due to minimal side effects and high treatment specificity. However, it often requires very high temperature to achieve complete tumor ablation under a single PTT. Such high temperature brings obvious thermal damage and inflammatory response to the body, affecting the therapeutic effect. In recent years, nitric oxide (NO) has been used to significantly inhibit tumor growth and enhance the sensitivity of tumor cells of temperature and drugs, thus enhancing the therapeutic effect. However, compounds as NO donors often have some disadvantages such as poor biocompatibility and untargeted delivery, etc., therefore, this medical application based on NO therapy is limited. In conclusion, the organic combination of NO donors and photothermal agents (PTAs) is expected to overcome the shortcomings of single therapy and achieve the antitumor effect of "1 + 1 > 2". In view of the rapid development of NO combining with PTT in tumor therapy, this review firstly introduces the antitumor mechanisms of different types of NO donors. Then the treatment strategy based on NO combined with PTT is discussed. Finally, the prospects and challenges of this combination therapy strategy in the clinical treatment of cancer are discussed.
